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ABSTRACT 
Background: Reactive pulmonary hypertension (PH) in left heart disease is associated with poor 
prognosis. This study aimed to evaluate the diagnostic utility of exercise ventilatory parameters on 
cardiopulmonary exercise testing for the diagnosis of reactive PH in patients with heart failure (HF) 
and reduced ejection fraction. 
Methods: This was a single-centre, retrospective analysis of a prospectively collected database of 
131 patients with HF who underwent in-hospital assessment for heart transplantation. Pulmonary 
hemodynamics was assessed by direct cardiac catheterization. Minute ventilation/carbon dioxide 
production (VE/VCO2) slope, partial pressure of end-tidal CO2 (ETCO2) changes on exercise, oxygen 
pulse, and exercise oscillatory ventilation were determined from cardiopulmonary exercise testing. 
Results: Sixty-one of 131 consecutive patients had reactive PH. VE/VCO2 slope (>41), change in 
ETCO2 on exercise (<1.2mmHg) and exercise oscillatory ventilation were independently associated 
with reactive PH. These 3 parameters in combination produced 3 possible diagnostic scenarios: (i) if 
all 3 criteria (“if all”) were present, (ii) if any 2 of the 3 criteria (“2 of 3”) were present and (iii) if any 
of the criteria (“if any”) were present. The corresponding positive/negative likelihood ratios for 
reactive PH if all 3 criteria were present were 3.73/0.83, if 2 of the 3 criteria were present were 
2.19/0.45, and if any of the 3 criteria were present were 1.75/0.11. The post-test probability 
increased from 46% to 76% (“if all” present) and reduced to 9% (if none of the criteria present).     
Conclusion: Ventilatory parameters on cardiopulmonary exercise test are associated with reactive 
PH in patients with HF. The absence of abnormalities in these 3 ventilatory parameters can 
effectively exclude reactive PH in patients with HF and poor ejection fraction.   
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BACKGROUND 
Pulmonary hypertension (PH) is commonly associated with left ventricular dysfunction, as elevation 
in left-sided filling pressure results in corresponding passive increase in pulmonary arterial pressure. 
However, some patients develop super-added pulmonary vascular disease, which may manifest as 
further elevation of transpulmonary gradient (TPG) or pulmonary vascular resistance (PVR) on 
cardiac catheterization – so-called reactive PH
1
. In some cases, the severity of reactive PH and 
elevation in TPG and PVR may appear disproportionate to the increase in left-sided filling pressure 
(pulmonary artery wedge pressure of ≤25mmHg), and this has been referred to as out-of-proportion 
pulmonary hypertension. An increase in mortality has been reported in patients with reactive PH 
and decompensated heart failure (HF)
2
. Reactive PH is also associated with poor outcomes from 
orthotopic heart transplantation, even if the abnormal pulmonary hemodynamics were reversible
3
. 
Therefore, the identification of reactive PH in left heart failure may guide prognosis and therapeutic 
interventions.  
 
Cardiopulmonary exercise testing is widely used in the assessment of the severity and prognosis in 
patients with HF. In particular, abnormal ventilatory response on exercise, as evidenced by an 
increased slope of ventilation to carbon dioxide (CO2) production (VE/VCO2), oscillatory ventilation 
and reduced partial pressure of end-tidal CO2 (ETCO2) are well described in patients with HF
4,5,6
. 
These abnormalities in ventilatory parameters in HF have been attributed to ventilation-perfusion 
mismatch, chemoreflex deregulation, ergoreceptor activation and reduced cardiac output
7
. Similar 
ventilatory abnormalities on cardiopulmonary exercise testing have been described in patients with 
pulmonary vascular disease
8
 and patients with PH associated with left heart disease
9
. Despite these 
well reported associations between ventilatory abnormalities, heart failure and PH, cardiopulmonary 
exercise testing has not been systematically evaluated for the diagnosis of reactive PH in left heart 
disease based on invasive cardiac catheterization. Hence, this study aimed to evaluate the utility of 
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ventilatory parameters on cardiopulmonary exercise testing for the diagnosis of reactive PH in 
patients with heart failure against the current standard of direct cardiac catheterization. 
 
METHODS 
Study Design and Patient Population 
We prospectively included consecutive ambulant patients with heart failure (New York Heart 
Association (NYHA) class III or IV) who underwent in-hospital assessment for heart transplantation 
between November 2011 and April 2013 at University Hospital Birmingham NHS Foundation Trust 
(Birmingham, United Kingdom). The patients completed all the assessments during their in-patient 
stay. Patients with congenital heart disease, acute decompensated heart failure or severe 
cardiogenic shock requiring inotropic support or urgent mechanical circulatory support (including 
intra-aortic balloon pump) were excluded from this study. Patients with significant contraindications 
or ‘too well’ for transplantation would not undergo in-hospital assessment and were not included. 
Baseline demographic data, including information on the medical history and current use of 
medications were collected from all the patients at the time of heart transplant assessment. The 
investigations/procedures were performed in accordance with our institution’s protocol for 
assessment for heart transplantation and approval from the NHS Research Ethics Committee was 
not required. 
 
Cardiopulmonary exercise test 
Each patient underwent a supervised, progressively increasing, symptom-limited cardio-pulmonary 
exercise testing (ramp protocol) on a treadmill. The ramp protocol was personalized to achieve a 
peak exercise of between 8-12 minutes. Ventilatory expired gas analysis was obtained with a 
metabolic cart (Powercube, Ganshorn Medizin Electronic). The oxygen and carbon dioxide sensors 
were calibrated before each test with gases with known oxygen, nitrogen, and carbon dioxide 
concentrations. The flow sensor was also calibrated before each test with a 3-L syringe. The oxygen 
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uptake (VO2), carbon dioxide production (VCO2), and minute ventilation (VE) were collected 
throughout the exercise test. PeakVO2 was expressed as the highest 30-s average value obtained 
during the last stage of the exercise test. Oxygen pulse is derived from VO2 divided by heart rate and 
the value at anaerobic threshold was reported as previous studies have shown that stroke volume 
estimation most closely approximated the directly measured stroke volume at anaerobic threshold, 
particularly in patients with significant heart failure
10
. Measurements of partial pressure of end-tidal 
CO2 at rest (Rest ETCO2) and at anaerobic threshold (ETCO2 AT) were collected as changes in end-
tidal CO2 during exercise has been well-reported in patients with heart failure and correlates with 
the severity of ventilation: perfusion mismatch
11,12
. Change in ETCO2 (delta ETCO2) was the 
difference in these 2 ETCO2 measurements. Ten-second averaged VE and VCO2 data, from the 
initiation of exercise (after the warm-up period) to the point of ventilatory threshold were used to 
calculate the VE/VCO2 slope. 
 
Exercise oscillatory ventilation was defined in accordance with the recent consensus statement as 
oscillatory wave amplitude of at least 15% of resting average VE, which persisted for at least 60% of 
the exercise
13
. 
Transthoracic echocardiography 
Transthoracic echocardiography was performed in accordance with standard guidelines. The left 
ventricular end-systolic, -diastolic volumes and ejection fraction (EF) were obtained by Simpson’s 
method from 2-dimensional apical images. The tricuspid annular plane systolic excursion (TAPSE) 
was measured by M-mode in the apical view as a measure of right ventricular function. Mitral and 
tricuspid regurgitation was quantified by Doppler in accordance with current recommendations
14
. 
Restrictive transmitral filling pattern was defined by an E/A ratio of > 2 and/or an E wave 
deceleration time of < 140ms
15
. 
 
Right heart catheterization 
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Right atrial (RA), right ventricular (RV), pulmonary artery (PA) and pulmonary artery wedge pressures 
(PAWP) were recorded at end-expiration with a balloon-tipped catheter. Cardiac output was 
measured by thermodilution (using an average of three measurements agreed within 10%) with 
cold, refrigerated injectate (5% glucose). Transpulmonary gradient (TPG) was calculated as: mean PA 
− mean PAWP. Pulmonary vascular resistance (PVR) in Woods units was calculated as: TPG/cardiac 
output. Pulmonary artery capacitance was calculated as stroke volume/pulmonary artery pulse 
pressure. Right ventricular stroke work (RVSW) was calculated as: SV x (mean PA – mean RA 
pressure) x 0.0136.  
 
Patients were divided into 3 groups based on their pulmonary hemodynamics: (i) no PH if mean PA 
pressure < 25mmHg; (ii) patients with passive PH if mean PA pressure > 25mmHg but PVR < 3WU 
and TPG < 12mmHg, and (iii) patients with reactive PH if mean PA pressure > 25mmHg and PVR > 
3WU or TPG ≥ 12mmHg. These criteria were based on current recommendations and guidelines
1,16
. 
 
Statistical Analyses 
Continuous variables are reported as mean ± standard deviation (SD) or median (Interquartile range, 
IQR) and categorical variables as proportions. Characteristics of the 3 groups of patients (no 
pulmonary hypertension, passive PH and reactive PH) were compared by ANOVA (and Tukey’s post 
hoc test) or Kruskall-Wallis for parametric and non-parametric data respectively. Multivariate 
analysis was performed to identify independent associations with the presence of reactive PH. The 
multivariate analysis included for baseline variables that were significantly different between groups 
(LVEF, LVESVi, T PSE, MR, NT pro-BNP and cardiopulmonary exercise test parameters). Mitral 
regurgitation was added to the model due to reported association with pulmonary hypertension. 
Receiver operating characteristic (ROC) curve analysis was used to assess the sensitivity/specificity of 
the ventilatory parameters for reactive PH. Sensitivity, specificity and likelihood ratios for the 
combined diagnostic criteria were then calculated for the presence of reactive PH. Likelihood ratio 
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for a positive test (LR+) is defined as sensitivity/(1-specificity) and likelihood ratio for a negative test 
(LR-) is defined as (1-sensitivity)/specificity. All statistical analyses were performed using R (version 
2.7.0) and a two sided p-value of <0.05 was considered statistically significant. 
 
RESULTS 
One hundred and thirty one consecutive patients with heart failure were included in this study. 
Seven patients were excluded – 3 patients unable to manage exercise test (one patient was an 
amputee, one patient suffered from left leg weakness due to prior stroke and one patient had leg 
weakness due to Becker’s muscular dystrophy), 4 did not reach anaerobic threshold.  Sixty-one of 
the 131 patients had reactive PH. Of the 7 excluded patients, 2 had reactive PH. We were unable to 
identify AT with confidence in 12 patients – 8 in the reactive and 4 in the non-reactive PH groups. All 
of whom had oscillatory ventilation on exercise. In the absence of identifiable AT, we used the peak 
value for calculating the delta ETCO2. This is based on previous studies indicating relatively minor 
change in ETCO2 from 50% load to peak exercise
11
. There were no significant differences in baseline 
demographics between groups. Patients with reactive PH were treated with higher doses of 
furosemide but there were no other statistically significant differences in conventional heart failure 
therapy [TABLE 1]. Patients with reactive PH had more severe right and left ventricular dysfunction, 
with suggestion of higher filling pressures from non-invasive tests, as evidenced by greater 
prevalence of restrictive transmitral filling pattern and NT pro-BNP levels.  
 
Patients with reactive PH had greater abnormalities on cardiopulmonary exercise test [TABLE 2] and 
pulmonary hemodynamics [TABLE 3]. On multivariate analysis, only VE/VCO2 slope (β=0.139, 
p<0.001), delta ETCO2 (β=-0.397, p=0.004) and exercise oscillatory ventilation (β=0.269, p=0.045) 
were independently associated with the presence of reactive PH. Ventilatory slope (r=0.451 and r=-
0.498) and delta ETCO2 (r=-0.361 and r=0.423) correlated with pulmonary vascular resistance and 
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pulmonary capacitance, respectively (all p<0.001). Change in VO2 from rest to peak exercise (delta 
VO2) was correlated with PVR (r=-0.269, p=0.002) and pulmonary capacitance (r=0.338, p<0.001). 
 
On ROC analysis, the AUC for VE/VCO2 slope delta ETCO2 and exercise oscillatory ventilation were 
0.79, 0.74 and 0.62; and the diagnostic threshold for VE/VCO2 slope of >41 and delta ETCO2 of <1.2 
provided the optimal balance of sensitivity and sensitivity. The odds ratios threshold for VE/VCO2 
slope of >41, delta ETCO2 <1.2 and exercise oscillatory ventilation were 6.86 (95% CI: 3.1-15.0), 3.27 
(95% CI: 1.58-6.75) and 2.1 (95% CI 1.01-4.62) respectively for the presence of reactive PH. These 3 
parameters formed the basis for the diagnostic criteria for reactive PH.  
 
The diagnostic value of these 3 ventilatory parameters were further analysed to determine their 
sensitivity, specificity and likelihood ratios. The number of patients who met the individual criteria is 
shown in FIGURE 1. These 3 parameters were then combined to produce 3 possible diagnostic 
scenarios: (i) if all 3 criteria (“if all”) were present, (ii) if any 2 of the 3 criteria (“2 of 3”) were present 
and (iii) if any of the criteria (“if any”) were present. The corresponding sensitivities and specificities 
for reactive PH if all 3 criteria were present were 21% and 94%, if 2 of the 3 criteria were present 
were 69% and 69%, and if any of the 3 criteria were present were 95% and 46%. A flow diagram in 
line with the STARTD initiative
17
 is shown in FIGURE 2.  
 
As the diagnostic value of a specific test is dependent on the prevalence of the condition in a 
population, the likelihood ratios (LR) were also computed to determine the diagnostic value of these 
3 ventilatory parameters for reactive PH based on the 46% prevalence of reactive PH in this study 
and also on a 50% lower prevalence of 23%. The likelihood ratios for positive and negative tests and 
the corresponding post-test probability of reactive PH are shown in TABLE 4. Despite the significant 
positive likelihood ratios, the post-test probability of these 3 criteria remained limited. In contrast, 
the likelihood of reactive PH is low in the absence of any of the 3 criteria in both high and low 
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prevalence conditions, and effectively excludes the presence of reactive PH in patients with heart 
failure.  
 
We also examined the subgroup of patients with out-of-proportion PH. There were 11 patients with 
‘out-of-proportion’ PH, characterized by TPG > 12, PVR > 3 and wedge pressure ≤ 25mmHg. Of these 
11 patients, 7 patients had 1 of 3, 2 patients had 2 of 3 and 2 patients had all 3 criteria. Therefore, 
the absence of any criteria excluded ‘out-of-proportion’ PH, based on our analysis in this small 
subgroup of patients. 
 
DISCUSSION 
This study evaluated the diagnostic utility of ventilatory parameters for reactive PH in heart failure. 
Three parameters were independently associated with reactive PH in this study: VE/VCO2 slope, 
delta ETCO2 and exercise oscillatory ventilation. These 3 parameters, applied in combination are 
associated with reactive PH in heart failure. However, our data suggest that the diagnostic utility of 
these ventilatory parameters lies predominantly in the exclusion of reactive PH in patients with 
heart failure, as the positive likelihood ratios and post-test probability were limited. 
 
Pulmonary hypertension is a well recognized complication of left heart failure. The association 
between pulmonary artery pressure and prognosis is well documented in patients with heart 
failure
18
, with more recent studies demonstrating increasing risk of adverse outcome with higher 
pulmonary vascular resistance and transpulmonary gradient
19
. Similar findings have been reported in 
patients with decompensated heart failure
2,20
. In addition, reactive PH is associated with poor 
outcomes from orthotopic heart transplantation
21
.  Hence, the identification of reactive PH in left 
heart disease may have clinically significant implications for treatment and prognosis.  
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Abnormalities in ventilatory parameters on cardiopulmonary exercise tests are well described in 
patients with PH and left heart disease. Previous studies have correlated these ventilatory 
abnormalities with hemodynamic changes
22
, pulmonary vascular disease
23
 and clinical outcomes
2425
. 
These observations formed the basis for further evaluation of PH in left heart disease against 
invasive cardiac catheterization, which is currently the accepted standard in clinical practice. Guazzi 
et al
26
 evaluated the use of cardiopulmonary exercise testing for the diagnosis of PH with left heart 
disease. The authors reported that a raised VE/VCO2 slope (>36), low peak ETCO2 response 
(<34mmHg) and the presence of exercise oscillatory ventilation predicted elevated pulmonary artery 
systolic pressure estimated on echocardiography. However, although useful, there are limitations in 
the use of echocardiography in estimating pulmonary artery pressures
27
. Hence, our study extends 
the findings reported by Guazzi et al with direct invasive hemodynamic measurements to define 
reactive PH, and our findings are consistent with these earlier reports on the association between 
ventilatory parameters on cardiopulmonary exercise testing and PH in left heart disease. The 
prevalence of ventilatory abnormalities on exercise, including exercise oscillatory ventilation was 
high in this study. We believe this reflects the heart failure severity in our patients, who were all 
referred for heart transplantation. Indeed, the clinical, echocardiographic and cardiopulmonary 
parameters are all consistent with a population of patients with advanced heart failure.  
 
A strong post-test probability of reactive PH with left heart disease may be intuitive in light of the 
well-documented association between abnormal ventilatory parameters and pulmonary vascular 
disease. Indeed, the positive likelihood ratios for all 3 scenarios (“if all”, “2 of 3” and “if any”) were 
statistically significant, which is consistent with the reported association between abnormal 
ventilatory parameters and pulmonary vascular disease. However, while abnormalities in all 3 
ventilatory parameters would increase the pre-test probability of 46% to a post-test probability of 
76%, the value of these ventilatory parameters as a “rule-in” test in clinical practice would be 
somewhat limited. In contrast, the negative likelihood ratio in the absence of any of these 
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ventilatory abnormalities may be clinically significant as a “rule-out” test, as it would reduce the pre-
test probability of 46% to a post-test probability of 9%, effectively excluding reactive PH in a 
population of patients with severe heart failure. The diagnostic value of these ventilatory 
parameters remained unchanged with an assumed lower (23%) prevalence of reactive PH. 
 
Patients with out-of-proportion PH represent a complex group. It is believed that these patients 
have mixed pulmonary vascular disease, which may have therapeutic implications. Based on a small 
number of patients with out-of-proportion PH, the absence of any of the 3 criteria appeared to 
exclude out-of-proportion PH in our study. These findings are preliminary and deserve further 
assessment.   
 
We did not specifically study patients with heart failure and normal ejection fraction (HFnEF). 
Pulmonary hypertension is well described in patients with HFnEF
28
, which is consistent with the 
prevailing paradigm of elevated left-sided filling pressure as the inciting stimulus for the 
development of pulmonary hypertension. Similar exercise ventilatory changes, including exercise 
oscillatory ventilation have been described in patients with HFnEF and PH
29,30
, which suggests similar 
pathophysiologcal changes (eg: ventilation-perfusion mismatch, chemoreflex deregulation, 
ergoreceptor activation and reduced cardiac output) in patients with heart failure irrespective of the 
measured ejection fraction. On this basis, we speculate that exercise ventilatory parameters would 
have similar diagnostic value in patients with HFnEF and PH, although they have not been 
systematically evaluated for the detection of reactive PH in these patients.  
 
Cardiopulmonary exercise testing has a well-established role in the assessment of heart failure. A 
number of exercise-derived parameters on cardiopulmonary exercise test have been described in 
heart failure, primarily for the assessment of prognosis
31,32
 since the initial description of VO2 in 
relation to heart transplantation
33
. Our study, building on the established association between 
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ventilatory abnormalities and adverse pulmonary hemodynamics, suggests that exercise ventilatory 
parameters may have diagnostic utility in excluding reactive PH in patients with heart failure. Our 
findings should not obviate the need for cardiac catheterization in patients undergoing assessment 
for heart transplantation as the pre-test probability is high, the consequences of transplant graft 
dysfunction in the face of adverse pulmonary hemodynamics are catastrophic and the risks of 
cardiac catheterization are low and may provide additional hemodynamic information to guide 
therapy and prognosis
34
.  However, our findings may be relevant in patients with less severe heart 
failure and low pre-test probability in effectively excluding reactive PH. A robust non-invasive 
assessment modality may also guide the therapeutic interventions (and response), as investigators 
continue to explore potential therapy in patients with PH and left heart disease
35
.  
 
Study limitations 
This study will have the inherent limitations of a single centre observational study, consisting of 
patients with severe heart failure undergoing assessment for transplantation. The latter in 
particular, may limit external validity when applied to the wider population of patients with less 
severe heart failure. Examination of the diagnostic value of these criteria using a lower prevalence of 
reactive PH (a lower prevalence of reactive PH was assumed in patients with less severe heart 
failure) may mitigate, but would not abolish this limitation.  Secondly, this is a relatively small study. 
However, we have endeavoured to characterize our patients in detail and our data should provide 
the basis for further evaluation and validation with a larger clinical study. In particular, mitral valve 
disease is associated with the development of PH, and combining echocardiographic assessment of 
mitral regurgitation with exercise ventilatory parameters may improve the positive likelihood ratio 
for reactive PH. The potential of combining multiple non-invasive modalities for the detection of 
reactive PH deserves further study. Finally, this study included only patients with PH in association 
with reduced left ventricular ejection fraction. Hence, the results may not be applicable to other 
forms of PH or in patients with preserved ejection fraction.  
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CONCLUSION 
Ventilatory parameters on cardiopulmonary exercise test are associated with reactive PH in patients 
with heart failure. The positive likelihood ratios of these parameters for reactive PH were statistically 
significant, but clinical applicability as a “rule-in” test may be limited. In contrast, the absence of any 
of these ventilatory abnormalities can effectively exclude reactive PH in patients with heart failure, 
and be useful as a “rule-out” test.  
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TABLE 1: Patient characteristics 
 Overall 
(n=131) 
No PH (n=21) Non-reactive 
PH (n=49) 
Reactive PH 
(n=61) 
P 
Age (years) 49 ± 11 49 ± 6 49 ± 3 50 ± 3 0.860 
Males (n, %) 107 (82) 76 92 75 0.067 
BMI 26 ± 4 25 ± 2 27 ± 1 27 ± 1 0.319 
Ischemic (n, %) 31 38 20 38 0.115 
AF (n, %) 30 38 20 34 0.184 
DM (n, %) 14 19 10 15 0.586 
QRSd (ms) 129 ± 28 115 ± 10 129 ± 8 133 ± 8 0.035* 
ICD (n, %) 44 33 43 49 0.437 
CRT (n, %) 42 29 45 44 0.396 
ACEi/ARB (n, %) 109 (83) 76 82 87 0.492 
B blockers (n, %) 109 (83) 86 78 87 0.405 
Aldos antag (n, %) 85 (65) 57 69 64 0.603 
Furosemide (mg/day) 80 (80-160) 80 (40-120) 80 (40-120) 120 (80-160) 0.043 
LVEF (%) 16 (10-20) 20 (15-30) 15 (10-20) 16 (10-20) 0.017* 
LVESVi (ml/m2) 91 ± 25 81 ± 9 89 ± 7 97 ± 7 0.032* 
TAPSE (mm) 13 (11-15) 16 (15-18) 12 (10-15) 12 (12-14) <0.001* 
RV diameter (cm) 3.7 (3.3-4.2) 3.4 (3.0-3.8) 3.7 (3.3-4.2) 3.8 (3.5-4.4) 0.085 
Restrictive (n, %) 49 5 43 69 <0.001* 
Severe MR (n, %) 43 29 37 53 0.091 
Na (mmol/l) 137 ± 4 138 ± 2 137 ± 1 136 ± 1 0.503 
eGFR (ml/min) 60 (47-80) 63 (52-88) 58 (48-79) 60 (43-74) 0.357 
NT pro BNP (ng/L) 2537 (809-
5615) 
1030 (535-
2360) 
3205 (935-
9201) 
3264 (1294-
5480) 
0.011* 
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BMI: body mass index; AF: atrial fibrillation; DM: diabetes mellitus; QRSd: QRS duration; ICD: 
implantable cardioverter-defibrillator; CRT: cardiac resynchronization therapy; ACEi: angiotensin 
converting enzyme inhibitor; ARB: angiotensin receptor blocker; B blocker: beta-blockers; aldos 
antag: aldosterone antagonist; LVEF: left ventricular ejection fraction; LVESVi: left ventricular end-
systolic volume index; TAPSE: tricuspid annular plane systolic excursion; RV: right ventricle; MR: 
mitral regurgitation; Na: sodium; eGFR: estimated glomerular filtration rate; NT pro BNP: N terminal 
pro B-natriuretic peptide 
Data as mean ± SD or median (interquartile range) 
*Significant difference in the No PH group compared to Reactive PH and Non-reactive PH groups 
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TABLE 2: Cardiopulmonary exercise test 
 Overall 
(n=131) 
No PH (n=21) Non-reactive 
PH (n=49) 
Reactive PH 
(n=61) 
P 
Peak VO2 (ml/kg/min) 10.6 ± 3.4 12.5 ± 2.1 11.0 ± 0.9 9.7 ± 0.7 0.003* 
Oxygen pulse (ml/beat) 7.9 ± 2.0 8.7 ± 0.7 8.4 ± 0.5 7.2 ± 0.5 <0.001* 
Circ power 
(mmHg.ml/min) 
1098 (837-
1387) 
1288 (995-
1730) 
1162 (872-
1365) 
1068 (809-
1295) 
0.044* 
VEVCO2 slope 41 (38-48) 36 (34-37) 40 (37-44) 46 (41-52) <0.001** 
Rest ETCO2 (mmHg) 25 (23-27) 26 (25-28) 26 (24-28) 23 (21-26) <0.001* 
AT ETCO2 (mmHg) 27 (23-29) 31 (28-35) 28 (25-31) 24 (21-26) <0.001* 
Delta ETCO2 (mmHg) 1.2 (0.2-3.1) 4.4 (2.5-6.2) 1.5 (0.7-3.7) 0.7 (-0.3-1.7) <0.001** 
Osc vent (n, %) 35 (27) 2 (9) 12 (25) 21 (34) 0.076** 
Circ power: circulatory power; ETCO2: end-tidal carbon dioxide; AT ETCO2: end-tidal carbon dioxide 
at anaerobic threshold; Osc vent: oscillatory ventilation 
Data as mean ± SD or median (interquartile range) 
*Significant difference in the reactive PH group compared to No PH and Non-reactive PH groups 
**Significant difference between all 3 groups 
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TABLE 3: Pulmonary hemodynamics 
 Overall 
(n=131) 
No PH (n=21) Non-reactive 
PH (n=49) 
Reactive PH 
(n=61) 
P 
Right atrial pressure 
(mmHg) 
14 (10-18) 8 (6-10) 15 (11-22) 15 (13-19) <0.001* 
PA systolic pressure 
(mmHg) 
53 (40-65) 30 (26-36) 48 (40-57) 65 (55-75) <0.001** 
PA diastolic pressure 
(mmHg) 
27 (20-33) 13 (10-16) 26 (23-31) 32 (26-36) <0.001** 
Mean PA pressure 
(mmHg) 
37 (29-46) 30 (12-23) 35 (29-40) 46 (38-52) <0.001** 
PA wedge pressure 
(mmHg) 
26 (20-32) 14 (10-16) 26 (20-30) 30 (25-35) <0.001* 
TPG (mmHg) 10 (7-13) 6 (5-7) 8 (7-10) 15 (12-19) <0.001** 
CO (L/min) 3.6 (3.0-4.1) 4.4 (3.6-4.9) 3.7 (3.3-4.3) 3.2 (2.8-3.7) <0.001* 
PVR (WU) 3.0 (2.1-4.1) 1.4 (1.1-1.7) 2.4 (1.9-2.7) 4.1 (3.6-5.9) <0.001** 
Pulm cap (ml/mmHg) 1.6 (1.3-2.3) 4.0 (2.5-4.5) 1.8 (1.5-2.4) 1.3 (1.0-1.5) <0.001** 
Mean BP (mmHg) 83 (75-90) 83 (71-88) 79 (72-86) 87 (79-93) 0.001† 
SVR (WU) 19 (16-24) 17 (15-20) 17 (15-20) 21 (19-27) <0.001† 
PVR/SVR ratio 0.16 (0.10-
0.20) 
0.08 (0.07-
0.10) 
0.14 (0.10-
0.16) 
0.20 (0.17-
0.26) 
<0.001** 
PA: pulmonary artery; TPG: transpulmonary gradient; CO: cardiac output; PVR: pulmonary vascular 
resistance; Pulm cap: pulmonary capacitance; BP: blood pressure; SVR: systemic vascular resistance 
Data as mean ± SD or median (interquartile range) 
*Significant difference in the No PH group compared to Reactive PH and Non-reactive PH groups 
**Significant difference between all 3 groups 
†Signiﬁcant diﬀerence in the reacZve PH group compared to No PH and Non-reactive PH groups 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18 
 
TABLE 4: Likelihood ratios at 2 levels of prevalence of reactive PH 
Criteria Prevalence (%) Likelihood ratio (95% CI) Post-test probability, % (95% CI) 
“If all” 46 LR+ 3.73 (1.28-11.0) 76 (53-91) 
LR- 0.83 (0.72-0.96) 42 (39-46) 
 23 LR+ 3.73 (1.33-10.0) 53 (28-75) 
LR- 0.83 (0.68-1.01) 20 (17-23) 
“2 of 3” 46 LR+ 2.19 (1.49-3.22) 66 (56-74) 
LR- 0.45 (0.30-0.68) 28 (21-37) 
 23 LR+ 2.19 (1.51-3.18) 40 (31-49) 
LR- 0.45 (0.26-0.78) 12 (7-19) 
“If any” 46 LR+ 1.75 (1.40-2.19) 60 (55-66) 
LR- 0.11 (0.03-0.33) 9 (3-22) 
 23 LR+ 1.75 (1.44-2.13) 34 (30-39) 
LR- 0.11 (0.02-0.53) 3 (1-14) 
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FIGURE 1: Number of patients who met the individual criteria 
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FIGURE 2: Flow diagram based on STARTD initiative.  
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Highlights 
 
Exercise ventilatory parameters for the diagnosis of reactive pulmonary hypertension in patients 
with heart failure 
 
1. Reactive pulmonary hypertension in left heart disease (PHLHD) is common in advanced heart 
failure. 
2. VE/VCO2>41, ETCO2 change<1.2 and oscillatory ventilation are associated with reactive PHLHD. 
3. The likelihood of reactive PHLHD increased 76% if all 3 criteria were present. 
4. The likelihood of reactive PHLHD reduced to 9% if none of the criteria were present.     
5. Absence of these 3 ventilatory abnormalities effectively excludes reactive PHLHD in heart failure 
 
